(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA1L mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1353078 6480464 epigallocatechin gallate results in decreased expression of HSPA1L mRNA CTD PMID:18851785 17alpha-ethynylestradiol increases expression ISO RGD:10741 6480464 Ethinyl Estradiol results in increased expression of HSPA1L mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:10741 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA1L mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:10741 6480464 Ethinyl Estradiol affects the expression of HSPA1L mRNA CTD PMID:17555576 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10741 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA1L mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA1L mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10741 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA1L mRNA CTD PMID:17942748 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:10741 6480464 tetrabromobisphenol A results in increased expression of HSPA1L mRNA CTD PMID:22677475 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1353078 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSPA1L mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1353078 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSPA1L mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation ISO RGD:10741 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of HSPA1L gene CTD PMID:31683443 4-hydroxynon-2-enal affects binding ISO RGD:1353078 6480464 4-hydroxy-2-nonenal analog binds to HSPA1L CTD PMID:18232660 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 Omeprazole inhibits the reaction [Ethanol results in increased expression of HSPA1L mRNA] CTD PMID:25637687 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of HSPA1L mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1353078 6480464 Acrylamide results in increased expression of HSPA1L mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1353078 6480464 Aflatoxin B1 results in increased methylation of HSPA1L gene CTD PMID:27153756 amphibole asbestos affects expression ISO RGD:1353078 6480464 Asbestos, Amphibole affects the expression of HSPA1L protein CTD PMID:20855422 antirheumatic drug increases expression ISO RGD:1353078 6480464 Antirheumatic Agents results in increased expression of HSPA1L mRNA CTD PMID:24449571 apigenin decreases expression ISO RGD:10741 6480464 Apigenin results in decreased expression of HSPA1L mRNA CTD PMID:22359648 arsane increases expression ISO RGD:1353078 6480464 Arsenic results in increased expression of HSPA1L protein CTD PMID:19818359 arsane affects methylation ISO RGD:1353078 6480464 Arsenic affects the methylation of HSPA1L gene CTD PMID:25304211 arsenic atom increases expression ISO RGD:1353078 6480464 Arsenic results in increased expression of HSPA1L protein CTD PMID:19818359 arsenic atom affects methylation ISO RGD:1353078 6480464 Arsenic affects the methylation of HSPA1L gene CTD PMID:25304211 arsenite(3-) increases expression ISO RGD:1353078 6480464 arsenite results in increased expression of HSPA1L mRNA CTD PMID:32406909 arsenous acid increases expression ISO RGD:1353078 6480464 Arsenic Trioxide results in increased expression of HSPA1L mRNA CTD PMID:27829220 atrazine decreases expression ISO RGD:1353078 6480464 Atrazine results in decreased expression of HSPA1L mRNA CTD PMID:22378314 Aurin increases expression ISO RGD:1353078 6480464 aurin results in increased expression of HSPA1L mRNA CTD PMID:25477506 benzo[a]pyrene increases methylation ISO RGD:1353078 6480464 Benzo(a)pyrene results in increased methylation of HSPA1L 5' UTR CTD PMID:27901495 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HSPA1L mRNA CTD PMID:25181051 , PMID:33296240 bisphenol A increases expression ISO RGD:10741 6480464 bisphenol A results in increased expression of HSPA1L mRNA CTD PMID:33221593 bisphenol A decreases methylation ISO RGD:1353078 6480464 bisphenol A results in decreased methylation of HSPA1L gene CTD PMID:28582417 bromoacetate decreases expression ISO RGD:1353078 6480464 bromoacetate results in decreased expression of HSPA1L mRNA CTD PMID:19753638 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of HSPA1L mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:1353078 6480464 Cadmium results in increased expression of HSPA1L mRNA CTD PMID:21120746 cadmium atom multiple interactions ISO RGD:1353078 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA1L mRNA CTD PMID:31738976 cadmium dichloride multiple interactions ISO RGD:1353078 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA1L mRNA CTD PMID:31738976 carbamazepine affects response to substance ISO RGD:1353078 6480464 HSPA1L gene SNP affects the susceptibility to Carbamazepine CTD PMID:16538175 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression ISO RGD:1353078 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of HSPA1L mRNA CTD PMID:16039398 CGP 52608 multiple interactions ISO RGD:1353078 6480464 CGP 52608 promotes the reaction [RORA protein binds to HSPA1L gene] CTD PMID:28238834 choline multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of HSPA1L protein CTD PMID:19566968 clofibrate multiple interactions ISO RGD:10741 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of HSPA1L mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSPA1L mRNA] CTD PMID:17585979 cobalt atom multiple interactions ISO RGD:1353078 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of HSPA1L mRNA CTD PMID:18078969 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of HSPA1L mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:1353078 6480464 [Disulfiram binds to Copper] which results in decreased expression of HSPA1L mRNA more ... CTD PMID:20971185 more ... copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of HSPA1L mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:1353078 6480464 [Disulfiram binds to Copper] which results in decreased expression of HSPA1L mRNA more ... CTD PMID:20971185 more ... copper(II) sulfate increases expression ISO RGD:1353078 6480464 Copper Sulfate results in increased expression of HSPA1L mRNA CTD PMID:19549813 crocin-1 multiple interactions EXP 6480464 crocin inhibits the reaction [Ethanol results in increased expression of HSPA1L mRNA] CTD PMID:25637687 crotonaldehyde increases expression ISO RGD:1353078 6480464 2-butenal results in increased expression of HSPA1L mRNA CTD PMID:20471460 D-penicillamine increases expression ISO RGD:1353078 6480464 Penicillamine results in increased expression of HSPA1L mRNA CTD PMID:22843330 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of HSPA1L mRNA CTD PMID:23640034 deoxynivalenol decreases expression ISO RGD:1353078 6480464 deoxynivalenol results in decreased expression of HSPA1L protein CTD PMID:33890134 desferrioxamine B multiple interactions ISO RGD:1353078 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA1L mRNA CTD PMID:12393473 dexamethasone multiple interactions ISO RGD:1353078 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSPA1L mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1353078 6480464 Arsenic Trioxide results in increased expression of HSPA1L mRNA CTD PMID:27829220 diethyl maleate increases expression ISO RGD:1353078 6480464 diethyl maleate results in increased expression of HSPA1L mRNA CTD PMID:33545341 diethylstilbestrol increases expression ISO RGD:10741 6480464 Diethylstilbestrol results in increased expression of HSPA1L mRNA CTD PMID:15171707 disulfiram multiple interactions ISO RGD:1353078 6480464 [Disulfiram binds to Copper] which results in decreased expression of HSPA1L mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:1353078 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA1L mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1353078 6480464 Doxorubicin results in increased expression of HSPA1L mRNA CTD PMID:29803840 ethanol multiple interactions EXP 6480464 crocin inhibits the reaction [Ethanol results in increased expression of HSPA1L mRNA], Omeprazole inhibits the reaction [Ethanol results in increased expression of HSPA1L mRNA] CTD PMID:25637687 ethanol increases expression EXP 6480464 Ethanol results in increased expression of HSPA1L mRNA CTD PMID:25637687 ferric ammonium citrate multiple interactions ISO RGD:1353078 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased expression of HSPA1L mRNA CTD PMID:12393473 folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of HSPA1L protein CTD PMID:19566968 formaldehyde increases expression ISO RGD:1353078 6480464 Formaldehyde results in increased expression of HSPA1L mRNA CTD PMID:20655997 , PMID:23649840 gemcitabine decreases expression ISO RGD:1353078 6480464 Gemcitabine results in decreased expression of HSPA1L mRNA CTD PMID:17039268 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HSPA1L mRNA CTD PMID:33387578 hemin multiple interactions ISO RGD:1353078 6480464 [Hemin results in increased abundance of Iron] which results in increased expression of HSPA1L mRNA CTD PMID:12393473 indometacin multiple interactions ISO RGD:1353078 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HSPA1L mRNA CTD PMID:28628672 iron atom multiple interactions ISO RGD:1353078 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA1L mRNA more ... CTD PMID:12393473 iron(0) multiple interactions ISO RGD:1353078 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA1L mRNA more ... CTD PMID:12393473 isoprenaline increases expression ISO RGD:10741 6480464 Isoproterenol results in increased expression of HSPA1L mRNA CTD PMID:20003209 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of HSPA1L mRNA CTD PMID:24286936 isoprenaline increases expression ISO RGD:1353078 6480464 Isoproterenol results in increased expression of HSPA1L mRNA CTD PMID:24286936 isoprenaline decreases expression ISO RGD:1353078 6480464 Isoproterenol results in decreased expression of HSPA1L mRNA CTD PMID:24286936 ivermectin decreases expression ISO RGD:1353078 6480464 Ivermectin results in decreased expression of HSPA1L protein CTD PMID:32959892 L-methionine multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of HSPA1L protein CTD PMID:19566968 L-serine increases expression ISO RGD:1353078 6480464 Serine results in increased expression of HSPA1L mRNA CTD PMID:29098664 Licochalcone B increases expression ISO RGD:1353078 6480464 licochalcone B results in increased expression of HSPA1L mRNA CTD PMID:33647349 linalool increases expression EXP 6480464 linalool results in increased expression of HSPA1L mRNA CTD PMID:20536181 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of HSPA1L protein CTD PMID:18296634 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of HSPA1L protein CTD PMID:18296634 mercury atom affects response to substance ISO RGD:1353078 6480464 HSPA1L gene polymorphism affects the susceptibility to Mercury CTD PMID:23330093 mercury(0) affects response to substance ISO RGD:1353078 6480464 HSPA1L gene polymorphism affects the susceptibility to Mercury CTD PMID:23330093 methylisothiazolinone increases expression ISO RGD:1353078 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of HSPA1L mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1353078 6480464 methylmercuric chloride results in increased expression of HSPA1L mRNA CTD PMID:28001369 monocrotaline multiple interactions ISO RGD:10741 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA1L mRNA CTD PMID:21224054 N-methyl-4-phenylpyridinium increases expression ISO RGD:1353078 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HSPA1L protein CTD PMID:24675778 nickel atom multiple interactions ISO RGD:1353078 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of HSPA1L mRNA] CTD PMID:14575637 nickel atom affects expression ISO RGD:1353078 6480464 Nickel affects the expression of HSPA1L mRNA CTD PMID:14575637 nitroprusside multiple interactions ISO RGD:1353078 6480464 [Nitroprusside results in increased abundance of nitrosonium ion] which results in decreased expression of HSPA1L mRNA CTD PMID:12393473 omeprazole multiple interactions EXP 6480464 Omeprazole inhibits the reaction [Ethanol results in increased expression of HSPA1L mRNA] CTD PMID:25637687 organoselenium compound multiple interactions ISO RGD:1353078 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of HSPA1L mRNA CTD PMID:25167922 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of HSPA1L mRNA CTD PMID:12486162 p-chloromercuribenzoic acid increases expression ISO RGD:1353078 6480464 p-Chloromercuribenzoic Acid results in increased expression of HSPA1L mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1353078 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA1L mRNA CTD PMID:27188386 paclitaxel increases expression EXP 6480464 Paclitaxel analog results in increased expression of HSPA1L mRNA CTD PMID:15585946 paracetamol multiple interactions ISO RGD:10741 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of HSPA1L mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HSPA1L mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:1353078 6480464 Acetaminophen results in increased expression of HSPA1L mRNA CTD PMID:21420995 paraquat decreases response to substance ISO RGD:1353078 6480464 HSPA1L protein results in decreased susceptibility to Paraquat CTD PMID:24887138 phenytoin multiple interactions ISO RGD:10741 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA1L mRNA CTD PMID:21224054 pioglitazone multiple interactions ISO RGD:1353078 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA, pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA] CTD PMID:20847119 pirinixic acid increases expression ISO RGD:10741 6480464 pirinixic acid results in increased expression of HSPA1L mRNA CTD PMID:18301758 quercitrin affects expression ISO RGD:1353078 6480464 quercitrin affects the expression of HSPA1L mRNA CTD PMID:25193878 rifampicin multiple interactions ISO RGD:10741 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of HSPA1L mRNA CTD PMID:21224054 rotenone increases expression ISO RGD:1353078 6480464 Rotenone results in increased expression of HSPA1L mRNA CTD PMID:29331484 SB 431542 multiple interactions ISO RGD:1353078 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA1L mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1353078 6480464 Silicon Dioxide results in increased expression of HSPA1L mRNA CTD PMID:25351596 silver atom increases expression ISO RGD:1353078 6480464 Silver results in increased expression of HSPA1L mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1353078 6480464 Silver results in increased expression of HSPA1L mRNA CTD PMID:26014281 sodium arsenite increases expression ISO RGD:10741 6480464 sodium arsenite results in increased expression of HSPA1L mRNA CTD PMID:16014739 sodium arsenite increases expression ISO RGD:1353078 6480464 sodium arsenite results in increased expression of HSPA1L mRNA CTD PMID:29301061 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of HSPA1L protein CTD PMID:29459688 styrene increases expression ISO RGD:1353078 6480464 Styrene results in increased expression of HSPA1L mRNA CTD PMID:24086524 sulforaphane affects binding ISO RGD:1353078 6480464 HSPA1L protein binds to sulforaphane CTD PMID:21838287 sunitinib increases expression ISO RGD:1353078 6480464 Sunitinib results in increased expression of HSPA1L mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:10741 6480464 Tamoxifen affects the expression of HSPA1L mRNA CTD PMID:17555576 teriflunomide decreases expression ISO RGD:1353078 6480464 teriflunomide results in decreased expression of HSPA1L mRNA CTD PMID:29427785 tert-butyl hydroperoxide multiple interactions ISO RGD:1353078 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression ISO RGD:1353078 6480464 tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA CTD PMID:20847119 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HSPA1L mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA1L mRNA] CTD PMID:31150632 thapsigargin decreases expression ISO RGD:1353078 6480464 Thapsigargin results in decreased expression of HSPA1L mRNA CTD PMID:22378314 thimerosal increases expression ISO RGD:1353078 6480464 Thimerosal results in increased expression of HSPA1L mRNA CTD PMID:16870260 thiostrepton increases expression ISO RGD:1353078 6480464 Thiostrepton results in increased expression of HSPA1L mRNA CTD PMID:22321511 titanium dioxide decreases expression ISO RGD:10741 6480464 titanium dioxide results in decreased expression of HSPA1L mRNA CTD PMID:29264374 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of HSPA1L mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1353078 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of HSPA1L mRNA] CTD PMID:14575637 triptonide increases expression ISO RGD:10741 6480464 triptonide results in increased expression of HSPA1L mRNA CTD PMID:33045310 troglitazone multiple interactions ISO RGD:1353078 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA, troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA] CTD PMID:20847119 troglitazone decreases expression ISO RGD:1353078 6480464 troglitazone results in decreased expression of HSPA1L mRNA CTD PMID:19631733 Tungsten carbide multiple interactions ISO RGD:1353078 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of HSPA1L mRNA CTD PMID:18078969 tunicamycin decreases expression ISO RGD:1353078 6480464 Tunicamycin results in decreased expression of HSPA1L mRNA CTD PMID:22378314 urethane increases expression ISO RGD:1353078 6480464 Urethane results in increased expression of HSPA1L mRNA CTD PMID:28818685 valproic acid increases methylation ISO RGD:1353078 6480464 Valproic Acid results in increased methylation of HSPA1L gene CTD PMID:29154799 zinc atom multiple interactions ISO RGD:1353078 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of HSPA1L mRNA CTD PMID:18593933 zinc pyrithione increases expression ISO RGD:1353078 6480464 pyrithione zinc results in increased expression of HSPA1L mRNA, pyrithione zinc results in increased expression of HSPA1L protein CTD PMID:19809895 , PMID:21424779 zinc sulfate increases expression ISO RGD:1353078 6480464 Zinc Sulfate results in increased expression of HSPA1L mRNA CTD PMID:16330358 zinc(0) multiple interactions ISO RGD:1353078 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of HSPA1L mRNA CTD PMID:18593933
